Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Marrow Failure”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07145411
What this trial is testing

HPC Offered for PRESERVE Expansion

Who this might be right for
Bone Marrow Transplant (BMT)
Ossium Health, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Not applicableStudy completedNCT01364363
What this trial is testing

Unrelated Donor Stem Cell Transplantation

Who this might be right for
Severe Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaAcute Myelogenous Leukemia+10 more
Scripps Health 64
Not applicableLooking for participantsNCT06606119
What this trial is testing

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

Who this might be right for
Trauma InjuryTraumaCritical Illness+3 more
University of Florida 275
Large-scale testing (Phase 3)Study completedNCT03825744
What this trial is testing

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Jiangsu HengRui Medicine Co., Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT00305708
What this trial is testing

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaFanconi Anemia+3 more
University of California, San Francisco 40
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Not applicableStudy completedNCT00244010
What this trial is testing

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Who this might be right for
Anemia, AplasticAmegakaryocytic ThrombocytopeniaDiamond-Blackfan Anemia+1 more
St. Jude Children's Research Hospital 4
Not applicableStudy completedNCT01900119
What this trial is testing

A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
National Institutes of Health Clinical Center (CC) 24
Testing effectiveness (Phase 2)Looking for participantsNCT02143830
What this trial is testing

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Who this might be right for
Fanconi AnemiaSevere Marrow FailureMyelodysplastic Syndrome (MDS)+1 more
Children's Hospital Medical Center, Cincinnati 70
Testing effectiveness (Phase 2)Study completedNCT01297972
What this trial is testing

Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

Who this might be right for
Aplastic Anemia
University of Sao Paulo 9
Testing effectiveness (Phase 2)UnknownNCT06518044
What this trial is testing

NAC for Hematopoietic Recovery in SAA

Who this might be right for
Aplastic Anemia
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06695741
What this trial is testing

Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaCyclophosphamide Reduced-doseImmunosuppressive Therapy
Institute of Hematology & Blood Diseases Hospital, China 75
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)UnknownNCT02407470
What this trial is testing

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Navy General Hospital, Beijing 90
Testing effectiveness (Phase 2)Study completedNCT05399732
What this trial is testing

Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Bing Han 58
Not applicableStudy completedNCT01768845
What this trial is testing

Unrelated Umbilical Cord Blood (UBC)Transplantation

Who this might be right for
Chronic Myelogenous Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome+6 more
West Virginia University 34
Testing effectiveness (Phase 2)Study completedNCT00144729
What this trial is testing

Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor

Who this might be right for
Anemia, Aplastic
Fred Hutchinson Cancer Center 85
Not applicableAvailableNCT04837703
What this trial is testing

Managed Access Programs for ETB115, Eltrombopag

Who this might be right for
Thrombocytopenia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Next Page